Skip to search formSkip to main contentSkip to account menu

chloroguanil, dapsone drug combination

Known as: chlorproguanil-dapsone, CPG-DDS, LAPDAP combination 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Background Chlorproguanil-dapsone (CD) has been linked to hemolysis in symptomatic glucose-6-phosphate dehydrogenase deficient… 
2011
2011
Cardiac toxicity has been reported with a number of antimalarial drugs. In this study we compared the cardiac effects of… 
2010
2010
Background Intermittent preventive treatment in infants (IPTi) has been shown to decrease clinical malaria by approximately 30… 
2010
2010
Background Intermittent preventive treatment in infants (IPTi) is a new malaria control tool. However, it is uncertain whether… 
Highly Cited
2009
Highly Cited
2009
BackgroundSulphadoxine-pyrimethamine (SP) is the only single dose therapy for uncomplicated malaria, but there is widespread… 
2009
2009
Effective and affordable treatment of malaria is critical in the face of resistance of Plasmodium falciparum to chloroquine (CQ… 
Highly Cited
2008
Highly Cited
2008
Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common inherited human enzyme defect. This deficiency… 
2003
2003
A new antimalarial drug, the product of a public-private partnership initiated by UK researchers, will soon hit the market in… 
Review
1999
Review
1999
Chlorproguanil-dapsone (CD) appears to be a promising anti-folate combination (Amukoye et al., 1997) to substitute for…